Company starts enrolling for injectable product trials in Canada
Positive data from bone graft test gets Franklin company closer to crucial FDA approval
Sam Lynch has BioMimetic on a steady growth path. Next up: Two important product launches [From our print edition featured in Monday's City Paper]
Private placement will be followed by larger rights offering
Lynch adopts trading plan to unload almost 1 percent of biotech's stock
LifePoint in talks to sell two hospitals, Gabelli keeps the faith in Gaylord, Vandy research says private prisons help save money, and more...
Private life proving good for iPayment, NHC buys in Carolina, local software firm on wrong end of $3M settlement, Hee Haw set for locally based network, and more...
Also: Adams to be interim CEO at NHI, BioMimetic insiders buy the dip
Guitar Hero maker tangles with Gibson, top execs changing at Nissan and GM in Spring Hill, an interim CFO at Cracker Barrel, BioMimetic sees '08 turnaround, and more...
BioMimetic's boss gets 46 percent raise, Psych Solutions and Renal Advantage buying again, local CFOs see steady job market, and more...
All Articles